ExpreS2ion Biotech Holding AB (publ)

OM:EXPRS2 Stock Report

Market Cap: SEK 39.2m

ExpreS2ion Biotech Holding Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Bent Frandsen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.9yrs
CEO ownershipn/a
Management average tenure3.9yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

We're Keeping An Eye On ExpreS2ion Biotech Holding's (STO:EXPRS2) Cash Burn Rate

Mar 07
We're Keeping An Eye On ExpreS2ion Biotech Holding's (STO:EXPRS2) Cash Burn Rate

ExpreS2ion Biotech Holding (STO:EXPRS2) Shareholders Have Enjoyed A Whopping 349% Share Price Gain

Feb 08
ExpreS2ion Biotech Holding (STO:EXPRS2) Shareholders Have Enjoyed A Whopping 349% Share Price Gain

CEO Compensation Analysis

How has Bent Frandsen's remuneration changed compared to ExpreS2ion Biotech Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 34m

Jun 30 2024n/an/a

-SEK 45m

Mar 31 2024n/an/a

-SEK 78m

Dec 31 2023n/an/a

-SEK 91m

Sep 30 2023n/an/a

-SEK 127m

Jun 30 2023n/an/a

-SEK 136m

Mar 31 2023n/an/a

-SEK 131m

Dec 31 2022n/an/a

-SEK 119m

Sep 30 2022n/an/a

-SEK 84m

Jun 30 2022n/an/a

-SEK 63m

Mar 31 2022n/an/a

-SEK 47m

Dec 31 2021SEK 2mSEK 2m

-SEK 44m

Compensation vs Market: Insufficient data to establish whether Bent's total compensation is reasonable compared to companies of similar size in the Swedish market.

Compensation vs Earnings: Insufficient data to compare Bent's compensation with company performance.

CEO

Bent Frandsen

4.9yrs

Tenure

SEK 1,962,000

Compensation

Mr. Bent U. Frandsen, MSc, has been Chief Executive Officer at ExpreS2ion Biotech Holding AB (publ) since December 20, 2019. He serves as Chief Executive Officer at ExpreS2ion Biotechnologies ApS. He serve...

Leadership Team

NamePositionTenureCompensationOwnership
Bent Frandsen
Chief Executive Officer4.9yrsSEK 1.96mno data
Keith Alexander
Chief Financial Officer4.1yrsno datano data
Max Sogaard
Senior Vice President of Research & Development and Technology3.7yrsno datano data
Farshad Guirakhoo
Chief Scientific Officer1.8yrsno datano data

3.9yrs

Average Tenure

Experienced Management: EXPRS2's management team is considered experienced (3.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jakob Knudsen
Independent Director7.6yrsSEK 108.00kno data
Martin Jensen
Chairman of the Board14.8yrsSEK 199.00kno data
Karin Garre
Independent Director3.5yrsSEK 54.00kno data
Sara Sande
Independent Director3.5yrsSEK 54.00k0.0048%
SEK 1.9k

5.5yrs

Average Tenure

60yo

Average Age

Experienced Board: EXPRS2's board of directors are considered experienced (5.5 years average tenure).